MedPath

博瑞制药(苏州)有限公司

Ownership
-
Established
2010-03-31
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Iopromide Injection

Product Name
碘普罗胺注射液
Approval Number
国药准字H20254086
Approval Date
May 13, 2025
NMPA

Iopromide Injection

Product Name
碘普罗胺注射液
Approval Number
国药准字H20254085
Approval Date
May 13, 2025
NMPA

Dienogest Tablets

Product Name
地诺孕素片
Approval Number
国药准字H20249468
Approval Date
Dec 1, 2024
NMPA

Carboprost Tromethamine Injection

Product Name
卡前列素氨丁三醇注射液
Approval Number
国药准字H20243336
Approval Date
Mar 12, 2024
NMPA

Fondaparinux Sodium Injection

Product Name
磺达肝癸钠注射液
Approval Number
国药准字H20233904
Approval Date
Jun 30, 2023
NMPA

Eribulin Mesilate Injection

Product Name
甲磺酸艾立布林注射液
Approval Number
国药准字H20233223
Approval Date
Feb 28, 2023
NMPA

Voriconazole for Injection

Product Name
注射用伏立康唑
Approval Number
国药准字H20233069
Approval Date
Jan 19, 2023
NMPA

Oseltamivir Phosphate for oral Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20223402
Approval Date
Jun 16, 2022
NMPA

Argatroban Injection

Product Name
阿加曲班注射液
Approval Number
国药准字H20223094
Approval Date
Mar 1, 2022
NMPA

Entecavir Tablets

Product Name
恩替卡韦片
Approval Number
国药准字H20223010
Approval Date
Jan 11, 2022
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.